Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Tetanus

Drug Information

Target Indication

Tetanus

Clinical Trial

Last updated: 1/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

SNY

Sanofi

Related Pipeline

Sleep Initiation and Maintenance Disorders

Hemophilia A

Ulcerative Colitis

Alzheimer Disease

Influenza

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts